In Brief This Week: Thermo Fisher Scientific; Exiqon; Complete Genomics; Appistry | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific this week said that it has established a new Biomarker Translational Center in Cambridge, Mass. The center is focused on mass spectrometry-based biomarker discovery research and the translation of those markers into the development of routine clinical assays. The firm said the new center combines its Brahms diagnostics product lines with the capabilities of its existing Biomarkers Research Initiatives in Mass Spectrometry Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.